Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Infect Dis Clin North Am. 1999 Mar;13(1):187-208, viii.

Anthrax vaccine. Model of a response to the biologic warfare threat.

Author information

  • Department of Internal Medicine, Parkview Hospital, Brunswick, Maine, USA.

Abstract

Anthrax vaccine is being administered to all 2.4 million active duty, reserve, and National Guard troops, as prophylaxis against biologic warfare. The vaccine's effectiveness in this setting may be limited. This article discusses unresolved issues of safety, with an emphasis on the need for careful surveillance of vaccines used by the military, which has sidestepped the commercial process. Also considered are ethical issues related to the development and use of military biologics, as the United States Army advances its Joint Vaccine Acquisition Program, a plan to produce more than ten vaccines specifically for biologic warfare threat, and to administer them to all military servicemembers.

PMID:
10198799
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk